Medicare Enrolled
Dr. Dee McCrary, MD
Family Medicine · Greenville, TX
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCrary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCrary?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCrary
Dr. Dee McCrary is a family medicine specialist in Greenville, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. McCrary performed 6,869 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McCrary received a total of $4,206 from 39 pharmaceutical and/or device companies across 270 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCrary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in TX
$4,206 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,869
Medicare services
Top 2% in TX for family medicine
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,851 | $34 | $65 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,461 | $29 | $48 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,075 | $35 | $55 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
549 | $35 | $47 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $88 | $157 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
273 | $2 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
196 | $58 | $106 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
141 | $77 | $125 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
138 | $124 | $130 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
117 | $0 | $15 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
98 | $25 | $26 |
| Annual alcohol misuse screening, 5 to 15 minutes | 95 | $18 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $10 | $22 |
| Annual depression screening | 61 | $18 | $21 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
60 | $14 | $20 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
48 | $79 | $103 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
38 | $61 | $110 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
28 | $11 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
22 | $9 | $23 |
| Chronic care management, first 30 minutes This service covers the initial 30 minutes of care coordination for patients with two or more chronic conditions. It is provided personally by a healthcare professional each calendar month. |
22 | $62 | $142 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
22 | $31 | $48 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
15 | $18 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,206
Total received (2018-2024)
Avg $601/year across 7 years
Top 15% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
270
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$377
2023
$390
2022
$402
2021
$671
2020
$826
2019
$667
2018
$872
Payments by company (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$120
AstraZeneca Pharmaceuticals LP
$72
Amgen Inc.
$48
Novartis Pharmaceuticals Corporation
$43
Astellas Pharma US Inc
$25
Lilly USA, LLC
$19
IDORSIA PHARMACEUTICALS US INC
$18
GlaxoSmithKline, LLC.
$17
ABBVIE INC.
$14
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$613
PFIZER INC.
$467
AstraZeneca Pharmaceuticals LP
$439
Lilly USA, LLC
$354
Amarin Pharma Inc.
$292
Janssen Pharmaceuticals, Inc
$258
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$198
Astellas Pharma US Inc
$185
Novartis Pharmaceuticals Corporation
$178
Merck Sharp & Dohme Corporation
$150
Novo Nordisk Inc
$135
IDORSIA PHARMACEUTICALS US INC
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Sunovion Pharmaceuticals Inc.
$75
GlaxoSmithKline, LLC.
$67
Mylan Specialty L.P.
$46
SANOFI-AVENTIS U.S. LLC
$39
Abbott Laboratories
$37
Bayer HealthCare Pharmaceuticals Inc.
$37
Medtronic, Inc.
$32
Eisai Inc.
$30
SANOFI PASTEUR INC.
$29
Exact Sciences Corporation
$29
ABBVIE INC.
$29
VBI Vaccines (Delaware) Inc.
$28
Clarus Therapeutics Inc.
$28
Philips Electronics North America Corporation
$25
Axsome Therapeutics, Inc.
$24
Cardiovascular Systems Inc.
$22
ACADIA Pharmaceuticals Inc
$22
Grifols USA, LLC
$20
Medicure Pharma Inc.
$20
Teva Pharmaceuticals USA, Inc.
$18
Genentech USA, Inc.
$18
Daiichi Sankyo Inc.
$18
Orexigen Therapeutics, Inc.
$16
Paratek Pharmaceuticals, Inc.
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Hologic, LLC
$14
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ADACEL · AIRSUPRA · AJOVY · ANORO · Aimovig · Aptima HPV · Auvelity · BASAGLAR · BELSOMRA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Dayvigo · Diamondback Peripheral · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · JATENZO · Kerendia · LATUDA · LEQVIO · LONHALA MAGNAIR · LYRICA · LifeVest · MOUNJARO · MYRBETRIQ · Myrbetriq · NUPLAZID · NUZYRA · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolastin-C · Prolia · QUVIVIQ · REYVOW · ROTATEQ · Rybelsus · SHINGRIX · SOLIQUA · STIOLTO RESPIMAT · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRULICITY · Tresiba · Utibron · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xofluza · Yupelri · ZYPITAMAG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
40
County median income
$70,112
Nearest hospital to ZIP centroid (approximate)
HUNT REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McCrary is a remote monitoring specialist, with above-average Medicare volume (top 2% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McCrary experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. McCrary performed 1,851 remote patient monitoring device, 30 days services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McCrary receive payments from pharmaceutical companies?
Yes. Dr. McCrary received a total of $4,206 from 39 companies across 270 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCrary's costs compare to other family medicine physicians in Greenville?
Dr. McCrary's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCrary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Greenville
Browse family medicine physicians in Greenville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology